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a B S T r a c T
iNTroDUcTioN: currently, abdominal obesity has reached an epidemic stage and obesity represents an important 
challenge for worldwide health authorities. epidemiologic studies have demonstrated that the stone risk incidence in-
creases with Body Mass index, through multiple pathways. Metabolic syndrome and diabetes are associated with an 
increased renal stones disease incidence. The aim of this systematic review was to investigate the prevalence, morbidity, 
risk factors involved in the association between obesity and urolithiasis.
EVIDENCE ACQUISITION: The search involved finding relevant studies from MEDLINE, EMBASE, Ovid, the Co-
chrane central register of controlled Trials, ciNaHl, google Scholar, and individual urological journals between 
January 2001 and May 2017. The inclusion criteria were for studies written in the english language, reporting on the 
association between obesity and urinary stones.
eViDeNce SYNTHeSiS: The underlying pathophysiology of stone formation in obese patients is thought to be related 
to insulin resistance, dietary factors, and a lithogenic urinary profile. Uric acid stones and calcium oxalate stones are 
observed frequently in these patients. insulin resistance is thought to alter the renal acid-base metabolism, resulting in a 
lower urine pH, and increasing the risk of uric acid stone disease. obesity is also associated with excess nutritional intake 
of lithogenic substances and with an increase in urinary tract infection incidence. recent studies highlighted that renal 
stone disease increases the risk of myocardial infarction, progression of chronic kidney disease, and diabetes. contempo-
rary, bariatric surgery has been shown to be associated with hyperoxaluria and oxalate nephropathy. certainly, the many 
health risks of obesity, including nephrolithiasis, will add more burden on urologists and nephrologists.
coNclUSioNS: obesity related nephrolithiasis seems to necessitate weight loss as primary treatment, but the recogni-
tion of the associated complications is necessary to prevent induction of new and equally severe medical problems. The 
optimal approach to obesity control that minimizes stone risk needs to be determined in order to manage obesity-induced 
renal stones disease.
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Introduction
according to WHo esteem, obesity is rapidly growing in the normal population and this 
seems to be dependent on diet and sedentary life 
style as a consequence of technological progress. 
The number of overweight people, that means 
people with a Body Mass index (BMi) >25 kg/
m2, was expected to grow from 1.6 million in 
2005, to 3.3 million in 2015. furthermore, the 
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number of obese subjects, that means people 
with a BMi>30, will increase from 400 million 
to 700 million in the same time span.1
on the other hand, the association between 
BMi and urolithiasis has been frequently report-
ed, with a prevalence of obesity in patients with 
kidney stone disease that varies, in the different 
studies, from 10% to 35%.2-5 curhan et al. in a 
cross-sectional analysis of Nurses’ Health Study 
(NHS; N.=89,376 women) and the Health Pro-
fessionals follow-up Study (HPfS), documented 
that the prevalence of stone disease was directly 
correlated to BMi for both women and men.6 
These results were, subsequently, confirmed by 
Taylor et al. who further underlined the effect of 
an increasing magnitude of obesity on the risk of 
kidney stone formation.7
according to a recent report, regarding the 
history of stone formation in a population of 
more than 12.000 participants, included in the 
2007-2010 National Health and Nutrition ex-
amination Survey (NHaNeS), the prevalence of 
nephrolithiasis in the USa is 8.4%.8 in men, the 
relative increase of stone formation, compared to 
1988-1994 NHaNeS data, was 63% (from 6.3% 
to 10.3%).8 The prevalence of kidney stones 
appeared to be higher among obese individu-
als (11.2%) and overweight individuals (9.1%) 
when compared to individuals of normal weight 
(6.1%). Moreover, a statistically significant cor-
relation between kidney stone formation and 
obesity was observed at the multivariate analy-
sis. Semings et al. investigated 95,598 subjects 
included in a national private insurance database, 
who were submitted to a median observation pe-
riod of approximately 3 and half years.2 overall 
the diagnosis of a kidney stone was done in 3.4% 
of the sample. During the evaluation period, 2.6% 
of subjects with a BMi less than 30 kg/m2 and 
4.9% of subjects with a BMi greater than 30 kg/
m2 were diagnosed with a kidney stone. except 
for men with a BMi greater than 50 kg/m, obese 
people were more frequently associated with a 
diagnosis of kidney stone compared to non-obese 
patients.2 Notably, this year the world kidney 
day was dedicated to the hidden consequences 
of obesity on kidney diseases.9 obesity causes 
both development of kidney disease and progres-
sion towards end stage renal failure. The mecha-
nisms whereby obesity produce renal damage re-
main still unclear. Nephrolithiasis is considered, 
among authors, one of the possible factors that 
contribute to increase the burden of renal damage 
carried by obesity.
Evidence acquisition
The objective of this systematic review was to 
investigate the prevalence, morbidity, risk fac-
tors, and the association between obesity and 
urolithiasis.
Search strategy
The search involved finding relevant studies 
from MeDliNe, eMBaSe, ovid, the cochrane 
central register of controlled Trials, ciNaHl, 
google Scholar, and individual urological jour-
nals between January 2001 and May 2017. The 
review was conducted in accordance with the 
systematic review guidelines provided by the 
cochrane collaboration and the Preferred re-
porting items for Systematic reviews and Meta-
analyses (PriSMa). Two reviewers (alP and 
GP) independently identified all studies that 
fitted the inclusion criteria for this review, and 
any discrepancy was resolved after adjudication 
and consensus with the senior author (aT). The 
search terms included the following ‘obesity,’ 
‘insulin resistance,’ ‘uric acid, ‘hypercalciuria,’ 
‘metabolic syndrome,’ ‘bariatric surgery,’ ‘re-
nal,’ ‘calculi,’ ‘stone(s),’ ‘urolithiasis’. These 
terms were combined using Boolean operators 
(AND, OR) to refine the search. The inclusion 
criteria focused on studies written in the english 
language, reporting on the association between 
obesity and urinary stones. Papers dealing with 
case reports and pediatric patients were not in-
cluded. The studies fitting the inclusion criteria 
were analyzed for the following: journal of pub-
lication, period of review, type of study, country 
of origin, population demographics (age, sex, 
BMi), stone composition.
Evidence synthesis
A total of 74 studies were identified from the 
literature search, 54 of which fitted completely 
the inclusion criteria (figure 1). among the ex-
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Taylor et al. found a difference in the urine 
composition of both stone-forming and non-
stone-forming subjects included in the Health 
Professionals follow up study and Nurses’ health 
study i and ii.12 Participants with greater BMi 
had lower urinary pH values and excreted more 
urinary oxalate, uric acid, sodium and phosphate 
compared to participants with lower BMi. a 
positive correlation between BMi and urinary 
calcium excretion was found only in men, inde-
pendently on the presence of stones, and stone-
forming younger women. This correlation how-
ever did not persist after adjustment for urinary 
phosphate and sodium excretion, suggesting that 
dietary proteins and sodium, rather than BMi 
determined the results. in this study a greater 
relative super-saturation of uric acid, but not of 
calcium oxalate, was found to be associated with 
the increasing BMi.12 Seiner examined a popu-
lation of more than 500 calcium oxalate stone 
former and found a linear correlation between 
urinary calcium excretion and BMi only in male 
subjects.13 a linear correlation between urinary 
calcium and BMi was found by Nouvenne in the 
group of female patients with idiopathic calcium 
nephrolithiasis, but not in the group of female 
controls.14
Negri examined a population of over 700 
stone formers, 61% of whom had a BMi>25, and 
found a significant increase of urinary oxalate, 
uric acid, phosphate and sodium with the increase 
of BMi, in both male and female patients.3 on 
the contrary no correlation was found, for both 
males and females, between urinary calcium and 
BMi. in this study citraturia was correlated with 
BMi only in the female population.3
The reviewed literature indicates that obesity 
is associated with an increased urinary excre-
tion of solutes responsible for stone formation, 
including calcium, oxalate and sodium and with 
a low urine pH. These abnormalities are partially 
counterbalanced by the increased urinary volume 
and citrate excretion.
Physiopathology
according to leman, body size is the major de-
terminant for urinary oxalate excretion among 
healthy adults, presumably reflecting variations 
cluded articles, two papers were case reports, 
one comment, and two papers where an updated 
article was available from the same authors.
BMI and urine composition
The studies investigating the influence of obesity 
on 24-hour urine composition in stone patients 
failed to give homogeneous results. Urine pH, 
an important factor for uric acid precipitation in 
urine, appeared to be inversely related to BMi in 
a study relative to a large number of patients with 
kidney stones.10 in another study of nearly 6000 
stone formers, Powell documented an increased 
urinary excretion of oxalate, calcium and uric acid 
in subjects weighing more than 120 kg compared 
to subjects weighing less than 100 kg. However 
urinary concentration of calcium and oxalate were 
similar in the 2 groups of patients due to differ-
ences in urine volume.11 ekeruo reported a greater 
prevalence of hypercalciuria, hyperoxaluria and 
hyperuricosuria in an obese population of stone 
formers compared to a non-obese population.4
Figure 1.—PRISMA flow diagram summarizing literature 
review.
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so that uric acid stone formation can easily take 
place.21 an excess of uric acid in urine can, also, 
induce the precipitation of calcium oxalate dehy-
drate, by a process of heterogeneous nucleation.22
Since an inverse correlation between BMi and 
urinary pH persists even after correction for uri-
nary sulfate, it is supposed that insulin resistance 
is independent on diet.9 This hypothesis is also 
supported by 2 observations: low glucose avail-
ability, caused by insulin resistance, is inversely 
correlated to urine pH; uric acid urolithiasis is 
more frequent in stone patients with diabetes 
mellitus compared to non-diabetic patients.20, 23 
Metabolic abnormalities responsible for stone 
formation in obesity, such as hypercalciuria and 
low urine pH, are mainly dependent on insulin 
resistance and partially on diet. oxalate excre-
tion is potentially related to body habitus and ci-
trate excretion is diet dependent.
Prevalence of metabolic risk factors and clinical 
evolution of nephrolithiasis
Hypercalciuria, gouty diathesis, hypocitraturia 
and a low urinary volume were found in more 
than 50% of obese patients included in a neph-
rolithiasis database.4, 24 other reported metabolic 
defects included hyperoxaluria and high urinary 
excretion of sulfate. all these metabolic abnor-
malities were statistically more represented in 
the obese compared to non-obese stone formers4 
(Table i). furthermore, urinary pH decreased, 
whereas the severity of hypercalciuria and hy-
peruricosuria increased with the severity of obe-
sity as determined by BMi.
lee et al. conducted a study on more than 700 
stone formers (Sf) and found that hypercalci-
uria, hyperuricosuria and low urinary volume 
were highly represented among obese patients 
as compared to non-obese patients.24 on the 
in endogenous oxalate synthesis with lean body 
mass.15 This finding, translated into the popula-
tion of stone formers, could justify the positive 
correlation between urinary oxalate excretion 
and BMi, frequently found in patients with neph-
rolithiasis.2, 3, 6, 11
in population studies, a positive correlation 
between urinary calcium excretion and body size 
was frequently reported.4, 11, 13 it is well known 
that one of the characteristics of obesity is insu-
lin resistance. as insulin is supposed to increase 
renal fractional excretion of calcium, it would be 
reasonable to speculate that insulin resistance is 
one of the mechanisms responsible for the higher 
calcium excretion in the obese stone former.16, 17 
On the other hand, the influence of diet on cal-
cium excretion in the obese stone former, must 
be taken in account.
in the study of Taylor et al., participants with 
higher BMi consumed more animal proteins and 
sodium (2 factors which increase urinary cal-
cium excretion), than their lower BMi counter-
parts.12 in fact, the positive correlation between 
body size and calcium excretion, found in men 
and young stone forming women, did not persist 
after correction for phosphate and sodium. ac-
cording to these results, the positive correlation 
between calcium excretion and BMi, frequently 
reported in previous studies, could be diet de-
pendent rather than secondary to modifications 
of renal physiology. in Taylor’s study, urinary 
saturation with respect to calcium oxalate and 
brushite appear to be normal in the obese popu-
lation, as a possible consequence of an increase 
of urinary volume and citrate excretion. in fact, 
urinary citrate has previously been reported by 
some authors to be increased in the obese popu-
lation, as a consequence of excessive assumption 
of fattening food and drinks.4, 11
increased uric acid excretion as well as a low 
urinary pH, are both responsible of urinary super-
saturation with respect to uric acid, found in pa-
tients with BMi>30.10, 12 Urinary pH <5.5 which 
corresponds to pK of uric acid, is supposed to be 
dependent on insulin resistance which, by the acti-
vation of the exchanger NH3 in the proximal renal 
tubule, reduces the synthesis and urinary excretion 
of ammonium.18-20 in acid urine, uric acid is pres-
ent under undissociated, easily precipitable form 
Table I.— Prevalence of patients presenting metabolic 
risk factors.4
% obese group % Non-obese group
gouty diathesis 54 18
Hyperuricosuria 43 20
Hypercalciuria 59 48
Hypocitraturia 54 63
Hyperoxaluria 31 10
High urine sulfate 70 24
low urine volume 58 70
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versely, the percentage of Ua stones raised with 
BMi in the male population, from 7.1% in nor-
mal BMi to 11.3% in overweight and 28.7% in 
obese patients (P<0.0001). The same trend was 
observed in the female patients. The percentage 
of Ua stones raised from 6.1% in the normal BMi 
group to 12.7% in overweight and up to 17.1% in 
obese groups (P=0.003). Moreover, the influence 
of overweight was mainly apparent in patients 
under 60-65 years of age, whereas an increasing 
age was the major factor in older subjects. Be-
cause a decreased ammonium excretion resulting 
in a lower urinary pH is frequent in the elderly, 
age-associated defective urinary acidification 
may be the major contributing factor to uric 
acid stone formation in older subjects.25-27 The 
analysis of more than 400 stones among obese 
patients, revealed that calcium oxalate monohy-
drated (66%) and uric acid (63%) were the prev-
alent components, followed by calcium oxalate 
dehydrated (31%).4 on the other hand, calcium 
oxalate monohydrated (88%) and dehydrated 
(68%) and apatite (68%) were the most common 
compositions in the non-obese group, in which 
uric acid stones were detected in 11% of patients.
on the base of current literature there are con-
vincing arguments that lead to suggest a role of 
obesity in favoring the formation of uric acid 
stones, where the major risk factors is represent-
ed by low urine pH and hyperuricosuria.27
Metabolic syndrome and kidney stone disease
The metabolic syndrome (MetS) is a clinical 
entity characterized by the presence of the fol-
lowing traits: obesity, dyslipidemia, hyperten-
sion and impaired glucose tolerance or diabetes 
mellitus.28 This syndrome of which obesity is 
supposed to be the driving component, is as-
sociated with an increased risk of cardiovascu-
lar disease, hyperuricemia and chronic kidney 
disease. according to community-based and a 
hospital-based studies, the prevalence of MetS 
is increased over the last decade to 30%.29, 30 in 
the Third National Health and Nutrition exami-
nation Survey, the prevalence of nephrolithiasis 
in individuals with MetS appeared to be 8.8% 
and it was shown to rise progressively with the 
number of MetS traits: 3% with zero traits, 7.5% 
with three traits and 9.8% with five traits.31 in 
contrary, the percentage of hypocitraturia was 
significantly lower among obese SF compared 
with non-obese Sf. clinical evolution of nephro-
lithiasis, including time to stone recurrence, was 
correlated to obesity only in patients at the first 
stone episode. These patients had a percentage 
of stone relapse at 5 years significantly higher in 
comparison to patients with normal weight (42% 
vs. 14.9%; P<0.012) and obesity was the only 
predictor of stone recurrence at the multivariate 
analysis. on the other hand, in patients with re-
current nephrolithiasis, the percentage of stone 
relapse was not statistically different in obese 
and non-obese stone formers (44.7% vs. 53.3%) 
and hypercalciuria was the only predicting factor 
at the multivariate analysis.24
in the study conducted by ekeruo et al. selec-
tive medical therapy proved to be useful in cor-
recting metabolic abnormalities and preventing 
stone recurrence in both normal weight and obese 
stone formers.4 Potassium citrate and allopurinol 
were the most frequently administered drug for 
the correction of gouty diathesis, hypocitraturia 
and unusually acidic urine. Moreover, all obese 
patients received dietary recommendations, aim-
ing specifically at the decreasing animal protein 
intake. Normalization of urinary calcium, citrate, 
sulfate and uric acid was obtained in the major-
ity of patients and these results translated into 
a decrease in the number of new stones formed 
yearly per patient (from 1.8 to 0.1).4
according to current evidence, metabolic de-
fects favoring stone formation are more repre-
sented in the obese patients than in the normal 
weight counterparts. However, selective medical 
therapy seems to be effective in preventing stone 
relapses independently on BMi.
BMI and stone composition
Daudon compared stone composition and anthro-
pometric data relative to more than 2000 stone 
patients and documented the major influence of 
an increasing BMi on the risk of forming uric 
acid (Ua) stones.5 in this paper 92.9% normal 
weight males produced calcium containing 
stones. This percentage was significantly higher 
compared to that found in the overweight group 
(88.7 vs. 92.9%, P=0.011) and, even more, in the 
obese group (71.3 vs. 92.9%, P<0.0001). con-
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attractant protein 1 and osteopontin, and mac-
rophage infiltration, activate the early phases of 
kidney stone formation.36, 37
in conclusion, the available data suggest that 
there is a link between MetS and nephrolithia-
sis and that the clinical activity of stone dis-
ease is directly correlated with the severity of 
MetS35-38 (Table ii).29, 32-34, 38
Bariatric surgery and new stone formation
according to large, randomized trials, patients 
who undergo bariatric surgery have sustained 
weight loss, decreased mortality and a lower in-
cidence of obesity-related complications, such as 
diabetes, hypertension, cardiovascular disease 
and obstructive sleep apnea.39, 40 among the dif-
ferent surgical techniques, roux-en-Y gastric 
bypass (rYgB), a mixed malabsorptive/restric-
tive operation, has represented, in recent years, 
the most popular bariatric procedure.41 However, 
both laboratory and clinical studies, have found 
that rYgB may be associated with enteric hyp-
eroxaluria and an increased risk of nephropathy 
and kidney stone disease.42-44 on the contrary, 
hyperoxaluria does not seem to arise after re-
strictive techniques, such as sleeve gastrectomy 
and adjustable lap banding, which are not report-
ed to be associated with a consistent risk of kid-
ney stone formation.45-47 This observation was 
confirmed by Lieske who compared 759 patients 
who underwent bariatric surgery to a matched 
group of obese patients belonging to the olmsted 
county. BMi was 46 for both groups and neph-
the study of rendina et al., 34% of an inpatient 
population of more than 2 thousand subjects had 
a positive diagnosis of MetS and 10.3% of them 
had an evidence of nephrolithiasis at ultrasound. 
The sonographic study documented a two-fold 
greater occurrence of nephrolithiasis in MetS 
patients compared with the remaining inpatient 
population. cox analysis revealed that there was 
an independent significant correlation among the 
evidence of renal stones, on one side and the di-
agnosis of MetS and the past history of KSD, on 
the other.32 These data appear to be confirmed in 
the study of Jeong et al. relative to a screened 
population of approximately 35 thousand Ko-
rean subjects. The presence of MetS had an or 
of 1.25 for kidney stone prevalence detected on 
the base of cT scan or sonography.33 Kohjimoto 
et al. in the retrospective analysis of 30,448 pa-
tients with urolithiasis, found a stepwise correla-
tion between the presence of one or more traits of 
MetS and the severity of kidney stone disease.34 
in this study, multivariate analysis revealed that 
the presence of MetS traits was associated not 
only with recurrent or multiple kidney stones, 
but also with the presence of abnormalities in 
urine constituents such as hypercalciuria, hyper-
uricosuria and hypocitraturia. Besides insulin re-
sistance that is strictly associated with obesity, 
the higher incidence of KSD could be induced by 
chronic inflammation, which is responsible of the 
complex metabolic derangements of MetS.35, 36 
recent studies suggest that the expression of in-
flammatory molecules, such as monocyte chemo 
Table II.— Major studies reporting association of MetS and kidney stones.
authors risk factors studied Patients follow-up results
Kohjimoto34 MetS 30,448 N/a recurrence of multiple stones related with traits of MetS:
zero 57.7%
one 61.7%
two 65.2%
three 69.3%
four 73.3%
rule38 Myocardial 
infarction
4564 Sf vs.
10,845 NSf
9 years or for Mi — 1.35 (stone formers had a 38% increased risk for Mi)
West29 MetS 33,994 N/a Prevalence of nephrolithiasis related with MetS traits:
3% with zero traits;
7.5% with three traits;
9.8% with five traits
rendina32 MetS 2132 N/a 10.3% echographic evidence of Nl, while 9.3% past history of Nl
Jeong33 MetS 34,895 N/a MetS or 1.25 (95% ci: 1.03-1.50) for kidney stone prevalence
MetS: Metabolic Syndrome; Mi: myocardial infarction; Nl: nephrolithiasis; or: odds ratio.
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rolithiasis at baseline had similar frequency in 
bariatric surgery patients and controls (4.0% vs. 
4.2%). over a mean follow-up period of 6.0 (3.2) 
years, new stone events were found to be more 
common in bariatric surgery patients than in 
obese controls (11.1% vs. 4.3%; P<0.01). Stone 
risk was dependent on the choice of specific type 
of bariatric surgery, being greatest in malabsorp-
tive procedures, intermediate in standard rYgB, 
and least in restrictive procedures.48
Previously Matlaga identified 4639 patients 
who had undergone rYgB and 4639 obese con-
trols, in a private insurance claims database.44 
over a median follow-up of 4 years, 7.65% of 
bariatric patients were shown to have developed 
a stone, compared with 4.63% of obese controls 
(odds ratio 1.71). The mean time from bariatric 
surgery to the stone event was 1.5 years, and 
rYgB patients were also more likely to undergo 
surgical stone removal (odds ratio 3.65).44
in conclusion bariatric surgery guarantees a 
longer survival and less comorbidities for the 
obese patient. These results, however, must be 
balanced against the fact that some bariatric pro-
cedures are associated with a consistent risk of 
kidney stone formation and nephropathy.49
Conclusions
The correlation between obesity and urinary 
stone is proved by numerous epidemiological 
studies. The process of lithogenesis is activated 
by some urine abnormalities, which appear to 
be more represented in the obese compared to 
the normal weight patient. Uric acid is the main 
stone composition and insulin resistance and diet 
are the mechanisms responsible of stone forma-
tion. Patients with metabolic syndrome seem to 
be as well affected by nephrolithiasis and there 
is a correlation between the presence of one or 
more traits of MetS and the severity of kidney 
stone disease. The benefits of bariatric surgery 
must be weighed in light of the possible subse-
quent onset of fat malabsorption and hyperox-
aluria which can lead to kidney stone formation 
and renal insufficiency. Hopefully in the next 
future, the discovery of the metabolic pathways 
leading lithiasis in obese patients will help to find 
more specific preventive therapies.
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